Podar, K. (2014). Efficacy of subcutaneous bortezomib in the management of patients with multiple myeloma or relapsed mantle cell lymphoma. Clinical medicine insights. Therapeutics, 6, . https://doi.org/10.4137/CMT.S9308
Chicago-Zitierstil (17. Ausg.)Podar, Klaus. "Efficacy of Subcutaneous Bortezomib in the Management of Patients with Multiple Myeloma or Relapsed Mantle Cell Lymphoma." Clinical Medicine Insights. Therapeutics 6 (2014). https://doi.org/10.4137/CMT.S9308.
MLA-Zitierstil (9. Ausg.)Podar, Klaus. "Efficacy of Subcutaneous Bortezomib in the Management of Patients with Multiple Myeloma or Relapsed Mantle Cell Lymphoma." Clinical Medicine Insights. Therapeutics, vol. 6, 2014, https://doi.org/10.4137/CMT.S9308.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.